Based on the longevity-related genes (i.e., Akt1, NRF1, parkin, and AIMP2), potentially effective therapeutics might be exploited for the rejuvenation and cure of age-associated neurodegenerative diseases. This evidence concerns the gene AIMP2 and neurodegenerative disease.